Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.